Mikko Niemi

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

Marja K. Pasanen, Mikko Neuvonen, Pertti J. Neuvonen et al. · Pharmacogenetics and Genomics · 2006 · 461 citations

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

Laura B. Ramsey, Samuel G. Johnson, Kelly E. Caudle et al. · Clinical Pharmacology & Therapeutics · 2014 · 437 citations · Full text

Slco1b1 Genotype, Lipid Disorder, Cardiovascular Disease +13

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

Marja K. Pasanen, Hanna Fredrikson, Pertti J. Neuvonen et al. · Clinical Pharmacology & Therapeutics · 2007 · 428 citations

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

Mikko Niemi, Elke Schaeffeler, Thomas Lang et al. · Pharmacogenetics · 2004 · 416 citations

ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

Jenni E. Keskitalo, Oliver Zolk, Martin F. Fromm et al. · Clinical Pharmacology & Therapeutics · 2009 · 413 citations